Abstract
Occurrence of endocrine abnormalities in acute renal failure (ARF) may be expected for the following reasons: (a) The kidney is an important endocrine organ, in which erythropoietin angiotensin I and II, active vitamin D metabolites, kinins, and prostaglandins are synthesized. (b) The kidney is an important excretory and biodegrading organ for hormones. (c) The kidney is the target organ of several hormones involved in the regulation of its excretory and endocrine functions. (d) ARF is caused by different etiological factors or is accompanied by deep alterations of the internal environment, which per se may influence secretion control of hormones, their transport, transformation, degradation, and binding to target cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hollenberg NK, Adams DF, Oken DE, Abrams HL, Merrill JPT. Acute renal failure due to nephrotoxins. Renal hemodynamic and angiographic studies in man. N Engl J Med 282: 1329–1334, 1970.
Hollenberg NK, Epstein M, Rosen SM, Basch RI, Oken DE, Merrill JP. Acute renal failure in men. Evidence for preferential renal cortisol ischemia. Medicine 47: 455–474, 1968.
Hollenberg NK, Sandor T, Controy M, Adams DS, Solomon HS, Abrams HL, Merrill JP. The transit of radioxenon through the oliguric human kidney: Analysis by the method of maximum likelihood. Kidney Int 3: 177–185, 1973.
Reubi FC, Vorburger C. Renal hemodynamics in acute renal failure after shock in man. Kidney Int 10: S137–S143, 1976.
Börner H, Klinkmann H. Pathogenesis of acute noninflammatory renal failure. Nephron 25: 261–266, 1980.
Kokot F. Die Pathophysiologie des akuten, nichtentzündlichen Nierenversagens. Z Ges Inn Med 33: 329–335, 1978.
Levinsky NG. Pathophysiology of acute renal failure. N Engl J Med 296: 1453–1458, 1977.
Kokot F, Kuska J. Influence of extracorporeal dialysis on insulin-induced human growth hormone secretion in patients with acute renal failure. Nephron 12: 241–248, 1974.
Pimstone BL, Le Roith D, Epstein S, Kronheim S. Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver diseases. J Clin Endocrinol Metab 41: 392–395, 1975.
Levitan D. Human and animal studies of the function of hypothalamic-pituitary-gonadal (H-P-G) axis during acute renal failure. In Acute Renal Failure, Eliahou HE (ed). London: John Libbey, 1982, p. 301.
Massry SG, Goldstein DA, Procci WR, Kletzky OA. On the pathogenesis of sexual dysfunction of the uremic male. Proc EDTA 17: 139–145, 1980.
Kokot F, Kuska J. Influence of hemodialysis in glucose utilization and insulin secretion in patients with acute renal failure. Eur J Clin Invest 3: 105–111, 1973.
Sagild U. Glucose tolerance in acute renal failure. Acta Med Scand 172: 405–411, 1962.
Henneman PH, Forbes AP, Moldawer M, Dempsey EF, Caroll EL. Effects of human growth hormone in man. J Clin Invest 39: 1223–1238, 1960.
Eskildsen PC, Sørenson OH, Bishop JE, Norman AW. Acromegaly and vitamin D metabolism: Effect of bromocriptine treatment. J Clin Endocrinol Metab 49: 484–486, 1979.
Spanos E, Barett D, MacIntyre I, Pike JW, Safilian EF, Haussler MR. Effect of growth hormone on vitamin D metabolism. Nature 273: 246–247, 1978.
Grzeszczak W, Kokot F, Dulawa J. Prolactin secretion in patients with acute chronic renal failure. Arch Immunol Ther Exp (in press).
Kokot F, Mleczko A, Pazera A. Parathyroid hormone and prolactin and function of the pituitary gonadal axis in male patients with acute renal failure. Kidney Int (in press).
Levitan D, Moser S, Goldstein DA, Kletzky O, Massry SG. Disturbances in the function of the hypothalamic-pituitary gonadal (H-P-G) axis during acute renal failure in the male. Kidney Int 19: 131, 1981.
Ferland L, Kabris F, Kelly PA, Raymond V. Interactions between hypothalamic and peripheral hormones in the control of prolactin secretion. Fed Proc 39: 2917–2920, 1980.
Isaac R, Merceron RE, Caillens G, Raymond JP, Ardaillou R. Effect of parathyroid hormone on plasma prolactin in man. J Clin Endocrinol Metab 47: 18–23, 1978.
Dobbie JW, Mountjoy D, Cowden EA, Allison MEM, Ratcliffe JG. Prolactin status in experimentally induced acute renal failure in the rat. Nephron 27: 316–319, 1981.
Spanos E, Colston KW, Evans IMS, Galante LS, McAuley SJ, McIntyre I. Effect of prolactin on vitamin D metabolism. Mol Cell Endocrinol 5: 163–167, 1967.
Kokot F. The endocrine system in patients with acute renal failure. Proc EDTA 18: 617–629, 1981.
Horky K, Sramkova J, Lachmanova, Tomasek R, Dvorakowa J. Plasma concentrations of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res 11: 241–246, 1979.
Massani ZM, Finkielman S, Worcel M, Agrest A, Paladini AC. Angiotensin blood levels in hypertensive and nonhypertensive diseases. Clin Sci 30: 473–483, 1966.
Ochoa E, Finkielman S, Agrest A. Angiotensin blood levels during the evolution of acute renal failure. Clin Sci 38: 225–231, 1970.
Paton AM, Lever AF, Cliver NWJ, Medina A, Briggs JD, Morton JJ, Brown JJ, Robertson JIS, Fraser R, Tree M, Gavras H. Plasma angiotensin II, renin substrate and aldosterone concentrations in acute renal failure in man. Clin Nephrol 3: 18–23, 1975.
Wong PY, Talamo RC, Wiliams GH. Kallikreinkinin and renin-angiotensin systems in functional renal failure of cirrhosis of the liver. Gastroenterology 73: 1114–1118, 1977.
Hofbauer KG, Konrads A, Bauereiss K, Möhring J, Gross F. Vasopressin and renin in glycerol-induced acute renal failure in the rat. Circ Res 41: 424–428, 1977.
Iaina A, Omdorff M, Gaveno S, Solomon S. ADH effect in development of ischemic acute renal failure. Proc Soc Exp Biol Med 163: 206–211, 1980.
Bodziony D, Kokot F, Czekalski S. Thyroid function in patients with acute renal failure. Intern Urol Nephrol 13: 81–88, 1981.
Kapstein EM, Levitan D, Feinstein EI, Nicoloff JT, Massry SG. Thyroid hormone indices in acute renal failure. Kidney Int 19: 129, 1981.
Czekalski S, Burton ST, Malczewska E, Kosowicz J, Baczyk K. Comparison of serum levels of thyroid hormones T4, T3, rT3 in dialyzed and nondialyzed uremics. Proceeding of the Second Int Congress for Artificial Organs, New York City, 1981, pp. 98-100.
Gomez-Pan A, Alvarez-Ude F, Yeo PPB, Hall R, Evered DC, Kerr DNS. Function of the hypothalamo-hypophysial-thyroid axis in chronic renal failure. Clin Endocrinol 11: 567–574, 1979.
Lim VS, Tang VS, Katz A, Refetoff S. Thyroid dysfunction in chronic renal failure. J Clin Invest 60: 522–534, 1977.
Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD. Thyroid function and metabolic state in chronic renal failure. Ann Intern Med 85: 724–730, 1976.
Weissel M, Stummvoll MK, Wolf A, Fritzsche H. Thyroid hormone in chronic renal failure. Ann Intern Med 86: 664–665, 1977.
Bravermann LE, Vagenakis AG. The thyroid. Clin Endocrinol Metab 8: 621–639, 1979.
Black AMS. Calcium, phosphate and parathyroid disturbances in acute renal failure. Anaesth Intensive Care 6: 342–349, 1978.
Fuss M, Bagon J, Dupont E, Manderlier T, Brauman H, Corvilain J. Parathyroid hormone and calcium blood levels in acute renal failure. With special reference to one patients developing transient hypercalcemia. Nephron 20: 196–202, 1978.
Fuss M, Bergans A, Geurts J, Brauman H, Corvilain J. Effect of rapid variation of renal function on plasma calcitonin and parathyroid hormone in man. Acta Endocrinol 92: 130–137, 1979.
Kokot F, Kuska J. Influence of extracorporeal dialysis on parathyroid hormone secretion in patients with acute renal failure. Nephron 16: 302–309, 1976.
Kovithavongs T, Becker FO, Ing TS. Parathyroid hyperfunction in acute renal failure. Serial studies in man. Nephron 9: 349–255, 1972.
Llach F, Felsenfeld AJ, Haussler MR. The pathophysiology of altered calcium metabolism in rhab-domyolysis-induced acute renal failure. Interactions of parathyroid hormone 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol. N Engl J Med 305: 117–123, 1981.
Massry SG, Arieff AI, Coburn JW, Palmieri G, Kleeman CR. Divalent ion metabolism in patients with acute renal failure: Studies on the mechanism of hypocalcemia. Kidney Int 5: 437–445, 1974.
Pietrek J, Kokot F, Kuska J. Kinetics of serum 25-hydroxyvitamin D in patients with acute renal failure. Am J Nutr 31: 1919–1926, 1978.
Pietrek J, Kokot F, Kuska J. Serum 25-hydroxyvitamin D and parathyroid hormone in patients with acute renal failure. Kidney Int 13: 178–185, 1978.
Turbkington RW, Deicher HK, Neelon PA. Hypercalcemia following acute renal failure. J Clin Endocrinol 28: 1224–1226, 1964.
Leonard CD, Eichner ER. Acute renal failure and transient hypercalcemia in idiopathic rhabdomyolysis. J Am Med Assoc 211: 1539–1540, 1970.
Weinstein RS, Rudson JB. Parathyroid hormone and 25-hydroxycholecalciferol levels in hypercalcemia of acute renal failure. Arch Intern Med 140: 410–411, 1980.
Wu BC, Pillary VKG, Hawker CD, Armbruster KFW, Shapiro MS, Ing TS. Hypercalcemia in acute renal failure of acute alcoholic rhabdomyolysis. South Afr J 46: 1631–1633, 1972.
De Torrente A, Berl T, Cohn PD, Kawamoto E, Hertz P, Schrier RW. Hypercalcemia of acute renal failure. Clinical significance and pathogenesis. Am J Med 61: 119–123, 1976.
Kokot F, Kuska J, Sledzinski Z, Pietrek J, Baczynski R. Serum calcitonin levels in patients with acute renal failure. Water Mineral Metab 4: 43–48, 1980.
Sommerville PJ, Kaye M. Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention. Kidney Int 16: 552–560, 1979.
Sommerville PJ, Kaye M. Resistance to parathyroid hormone in renal failure: Role of vitamin D metabolites. Kidney Int 14: 245–254, 1978.
Massry SG, Stein R, Garty J, Arieff AI, Coburn JW, Normann AW, Friedler RM. Skeletal resistance to the calcemic action of parathyroid hormone in uremia: Role of 1,25(OH)2D2. Kidney Int 9: 467–474, 1976.
Ølgaard K, Schwartz J, Finco D, Martin K, Korkor A, Font EB, Arbelaez M, Klahr S, Slatopolsky E. The extraction of PTH (1–34) and the generation of cAMP by isolated perfused bones from acutely uremic dogs. Kidney Int 19: 210, 1981.
Gautvik KM, Tashjian AH Jr. Effects of cations and colchicine on the release of prolactin and growth hormone by functional pituitary tumor cells in culture. Endocrinology 93: 793–799, 1979.
Ardaillou R, Beaufils M, Nivez M-P, Isaac R, Mayard C, Sraer J-D. Increased plasma calcitonin in early acute renal failure. Clin Sci Mol Med 49: 301–304, 1975.
Kokot F, Kuska J, Mleczko Z, Szczechowska E, Pazera A. Uber die Beziehung zwischen Gastrin-und Kalzitonin-Sekretion bei Kranken mit akuter und chronischer Niereninsuffizienz. Dtsch Gesundh-Wesen 36: 429–432, 1981.
Heynen G, Franchimont P. Human calcitonin and serum phosphate. Lancet I: 267, 1974.
Hennesy JF, Gray TK, Cooper CW, Ontjes DA. Stimulation of thyrocalcitonin by pentagastrin and calcium in two patients with medullary carcinoma of the thyroid. J Clin Endocrinol Metab 36: 200–203, 1973.
Melvin KEW, Voelkel EF, Tashjian AH Jr: Medullary carcinoma of the thyroid: Stimulation by calcium and glucagon of calcitonin secretion. In Taylor and Foster, Calcitonin 1969, Proc 2nd Int Symp, London, Heineman Medical, 1969, pp. 487-496.
Dulawa J, Kokot F, Grzeszczak W. Function of the adrenal cortex in acute renal failure (in press).
Brown JJ, Gleadle RI, Lawson DH, Lever AF, Linton AL, Mac Adam RF, Prentice E, Robertson JIS, Tree M. Renin and acute renal failure: Studies in man. Br Med J 1: 253–258, 1970.
Kokot F, Kuska J. Plasma renin activity in acute renal insufficiency. Nephron 6: 115–127, 1969.
Kokot F, Kuska J. Plasma renin activity in patients with acute and chronic renal insufficiency treated by hemodialysis. Proc. EDTA 8: 542–545, 1971.
Kokot F, Kuska J. Die Aldosteronämie bei Kranken mit akuter Niereninsuffizienz. Z Ges Inn Med 31: 144–148, 1976.
Mydlik M, Langos, Novotny J, Blazicek P, Derzsiova K, Takac M. Plasmaticka reninova aktivita pri akutnej oblickovej nedostatocnosti. Vnitr Lek 24: 1–10, 1978.
Schröder E, Herms W, Wetzeis E, Dume T, Grabensee B. Plasma-Renin bei akuter und chronischer Niereninsuffizienz und Hämodialyse. Dtsch Med Wochenschr 94: 2262–2267, 1967.
Stone RA, Tisher CC, Hawkins HK, Robinson RR. Juxtaglomerular hyperplasia and hyperreninemia in progressive systemic sclerosis complicated by acute renal failure. Am J Med 56: 119–123, 1974.
Tu WH. Plasma renin activity in acute tubular necrosis and other renal disease with hypertension. Circulation 31: 686–695, 1965.
Blachley JD, Henrich WL. The diagnosis and management of acute renal failure. Semin Nephrol 1: 11–19, 1981.
Kleinknecht D. Donnes recentes sur la physipathologie des nephrites tubulares aique. Pathol Biol (Paris) 29: 197–205, 1980.
Schrier RW, Burke TJ, Conger JD, Arnold PE. Newer aspect of acute renal failure. Proc 8th Int Congr Nephrol Athens, 1981 pp 63-69.
Stein JH, Patak RV, Lifschitz MD. Acute renal failure: Clinical aspects and pathophysiology. Contrib Nephrol 14: 118–141, 1978.
Thurau K, Boylan JW, Mason J. Pathophysiology of acute renal failure. In Renal Disease, Black D, Jones NF (eds). Oxford; Blackwell Scientific Publication, 1979, pp. 64–92a.
Birkhäuser M, Riondel A, Valloton MB. Bromocriptine-induced modulation of plasma aldosterone response to acute stimulation. Acta Endocrinol 91: 294–302, 1979.
Bilbrey GL, Faloona GR, White MG, Knochel JP, Borroto J. Hyperglucagonemia in renal failure. J Clin Invest 53: 841–847, 1974.
Dent RI, Hirsch, James JH, Fischer JE. Hypergastrinemia in patients with acute renal failure. Surg Forum 23: 312–313, 1972.
Falcao NA, Wesdorf RIC, Fischer JE. Gastrin levels and gastric acid secretion in anephric patients and in patients with chronic and acute renal failure. J Surg Research 18: 107–111, 1975.
Kokot F, Król Z, Makowski C, Bodziony D. Serumgastrin bei Patienten mit akuten Nierenversagen. Z Ges Inn Med 34: 753–755, 1979.
Kuska J, Kokot F, Gerlach J. Zachowanie sie gastrynemii po stymulacji jonami wapnia u chorych z ostra i przewlekła niewydolnościa nerek. Pol Arch Med Wewn 63: 149–155, 1980.
Davidson WO, Moore TC, Shipey W, Convaloff AJ. Effect of bilateral nephrectomy and bilateral ureteral ligation on serum gastrin levels in the rat. Gastroenterology 66: 522–525, 1974.
Oken DE. Role of prostaglandins in the pathogenesis of acute renal failure. Lancet 1: 1319–1322, 1975.
Vincenti F, Goldberg LI. Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome. Prostaglandins 15: 463–472, 1978.
Mauk RH, Patak RV, Fadem SZ, Lifschitz MF, Stein JH. Effect of prostaglandin E administration in a nephrotoxic and a vasoconstrictor model of acute renal failure. Kidney Int 12: 122–130, 1977.
Robinson PJA, Gaunt A, Leung WK, Ima G, McLachlan MSF. Failure of prostaglandin A1 to modify renal diatrizoate uptake in experimental acute renal failure. Invest Radiol 13: 150–154, 1978.
Henrick WL, Blachley JD. Acute renal failure with prostaglandin inhibitors. Semin Nephrol 1: 57–60, 1981.
Morrison AR, Thornton F. Thromboxane A2-major prostaglandin of human hydro-nephrotic kidney. Kidney Int 19: 224, 1981.
Agranenko VA, Komarov LS, Chizhova AI. Erythropoietin and ceruloplasmin in acute renal insufficiency (in Russian). Ter Arkh 40: 77–81, 1968.
Wong PY, Talamo RC, Wiliams GH, Colman RW. Response of kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest 55: 691–698, 1975.
Nasjletti A, Malik KU. Renal kinin-prostaglandin relationship implications for renal function. Kidney Int 19: 860–868, 1981.
Editor information
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Kokot, F. (1984). Endocrine System in Acute Renal Failure. In: Andreucci, V.E. (eds) Acute Renal Failure. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2841-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2841-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9794-9
Online ISBN: 978-1-4613-2841-4
eBook Packages: Springer Book Archive